Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61826 | NLRP3-IN-4 | ||
NLRP3-IN-4 is a highly efficient and orally bioavailable inhibitor of NLRP3 inflammasome, which exhibits strong anti-inflammatory properties specifically targeted towards colitis. | |||
T3230 |
NLRP3-IN-2
5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide,4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺,NLRP3 Inflammasome Inhibitor I |
NOD-like Receptor (NLR); NOD | Immunology/Inflammation; NF-κB |
NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide) 是一种能够合成格列本脲的中间物,对心肌细胞中NLRP3炎症小体的形成具有抑制作用,在小鼠心肌缺血/再灌注后限制梗死面积,且对代谢无影响。 | |||
T39552 |
NLRP3-IN-5
NLRP3-IN-5 |
||
NLRP3-IN-5, a compound disclosed in WO2016131098, is an inhibitor of NLRP3 inflammasome. It consists of the chemical structure N-((4-chloro-2,6-dimethylphenyl)carbamoyl)-4-(2-hydroxypropan-2-l)furan-2-sulfonamide. | |||
T81666 |
NLRP3-IN-22
|
NOD-like Receptor (NLR) | Immunology/Inflammation |
NLRP3-IN-22 (Compound II-4) 作为NLRP3抑制剂,展现出在10 μM浓度下67%的抑制效果。 | |||
T60868 | NF-κB-IN-4 | ||
NF-κB-IN-4 (化合物 17) 是有效的NF-κB 通路抑制剂,可透过血脑屏障(BBB)。NF-κB-IN-4 具有潜在的抗神经炎症活性,毒性低,可用于研究神经炎症相关疾病。NF-κB-IN-4 可阻断 IκBα 的活化及磷酸化,降低 NLRP3 的表达,从而抑制NF-κB 的激活。 | |||
T81579 |
P2X7 receptor antagonist-4
|
||
P2X7 receptor antagonist-4(Compound 14a)是一种选择性P2X7R拮抗剂,其对人类和小鼠P2X7R的IC50值分别为64.7 nM和10.1 nM。该化合物能有效抑制NLRP3炎性体的激活,并在脓毒症模型小鼠中减少肾损伤,降低caspase-1、gasdermin D、IL-1β和IL-18的表达。 | |||
T38106 |
JC-171
|
||
JC-171 is a selective NLRP3 inflammasome inhibitor, with an IC50 of 8.45 μM for inhibiting LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages[1]. JC-171 (0-100 μM) blocks NLRP3 inflammasome activation and IL-1β production in primary macrophages dose dependently[1]. ... |